Charlene Blake, MD, PhD
Associate Professor
Anesthesia
School of Medicine

Education & Training

Show all (6) Hide

• Diversity, Equity, and Inclusion Champion Training University of California 2018
• Cardiothoracic Anesthesiology Fellowship Washington University in St. Louis 06/2015
• Anesthesiology Residency Washington University in St. Louis 06/2014
• MD (Medical Scientist Training Program) Duke University School of Medicine 05/2010
• PhD Genetics and Genomics Duke University Graduate School 05/2009
• BA Chemistry Fisk University 05/2002

Grants and Projects

Show all (2) Hide

• EEG-guided cardiac anesthesia to reduce intraoperative burst suppression and postoperative delirium, Department of Anesthesia and Perioperative Care, SOM, UCSF, 2016-2018
• Enhancement of Thrombolysis through Inhibition of PAI-1 and Antiplasmin, NIH, 2007-2008

Publications (9)

Top publication keywords:
RNAThrombinVitronectinBrain IschemiaAnesthesiologyPlasminogen Activator Inhibitor 1Aptamers, NucleotideMetoprololAnesthesiologistsFactor IXaCerebral HemorrhageCytochrome P-450 CYP2D6Anesthesia, Cardiac ProceduresAdrenergic beta-AntagonistsAntidotes

• In Reply to Nakajima and to Davis and Park.
  Academic medicine : journal of the Association of American Medical Colleges 2022 Poorsattar SP, Blake CM, Manuel SP
• Addressing Microaggressions In Academic Medicine.
  Academic medicine : journal of the Association of American Medical Colleges 2021 Poorsattar SP, Blake CM, Manuel SP
• Quotas or mission? The importance of diversity in anesthesiology.
  Journal of clinical anesthesia 2019 Boulos NM, Burton BN, Blake CM, Gabriel RA
• Ethnic Disparities in Cardiothoracic Anesthesiology Fellowship Training.
  Journal of cardiothoracic and vascular anesthesia 2019 Burton BN, Boulos NM, Wilkins Y Martinez L, Gabriel RA, Blake CM
• A meta-analysis of CYP2D6 metabolizer phenotype and metoprolol pharmacokinetics.
  Clinical pharmacology and therapeutics 2013 Blake CM, Kharasch ED, Schwab M, Nagele P

Show all (4 more) Hide

• Effects of plasminogen activator inhibitor-1-specific RNA aptamers on cell adhesion, motility, and tube formation.
  Nucleic acid therapeutics 2011 Brandal S, Blake CM, Sullenger BA, Fortenberry YM
• A reversible aptamer improves outcome and safety in murine models of stroke and hemorrhage.
  Oligonucleotides 2010 Blake CM, Wang H, Laskowitz DT, Sullenger BA
• Development of universal antidotes to control aptamer activity.
  Nature medicine 2009 Oney S, Lam RT, Bompiani KM, Blake CM, Quick G, Heidel JD, Liu JY, Mack BC, Davis ME, Leong KW, Sullenger BA
• Antimetastatic potential of PAI-1-specific RNA aptamers.
  Oligonucleotides 2009 Blake CM, Sullenger BA, Lawrence DA, Fortenberry YM